Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Hayashi, Atsushi ^a   Tanabe, Akiko ^a   Kawabe, Sachiko ^a   Hayashi, Mika ^a   Yuguchi, Hiroko ^a   Yamashita, Yoshiki ^a   Okuda, Kiyoji ^a   Ohmichi, Masahide ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Dienogest; Estrogen receptor isoforms; Ovarian endometriosis; Progesterone receptor isoforms; Progesterone resistance

Indexed keywords

CA 125 ANTIGEN; DIENOGEST; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LEUPRORELIN; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; LEIOMYOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; VISUAL ANALOG SCALE;

EID: 84868219071     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-5-31     Document Type: Article

References (45)

1. Endometriosis. Giudice LC, Kao LC, Lancet 2004 364 1789 1799 10.1016/S0140-6736(04)17403-5 15541453
2. Epidemiology of endometriosis. Eskenazi B, Warner ML, Obstet Gynecol Clin North Am 1997 24 235 258 10.1016/S0889-8545(05)70302-8 9163765
3. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Allen C, Hopewell S, Prentice A, Gregory D, Cochrane Database Syst Rev 2009 2 D004753 10.1002/14651858 19370608
4. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Brown J, Pan A, Hart RJ, Cochrane Database Syst Rev 2010 12 D008475 21154398
5. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Sagsveen M, Farmer JE, Prentice A, Breeze A, Cochrane Database Syst Rev 2003 4 D001297 14583930
6. Non-contraceptive benefits of hormonal contraceptives. Schindler AE, Minerva Ginecol 2010 62 319 329 20827249
7. Treatment of endometriosis. Olive DL, Pritts EA, N Engl J Med 2001 345 266 275 10.1056/NEJM200107263450407 11474666
8. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Waller KG, Shaw RW, Fertil Steril 1993 59 511 515 8458449
9. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Vercellini P, Cortesi I, Crosignani PG, Fertil Steril 1997 68 393 401 10.1016/S0015-0282(97)00193-3 9314903
10. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, Attar E, Innes J, Julie Kim J, Mol Cell Endocrinol 2006 248 94 103 10.1016/j.mce.2005.11.041 16406281
11. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW, Biochem Biophys Res Commun 1987 149 493 501 10.1016/0006-291X(87)90395-0 3426587
12. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P, Gronemeyer H, J Biol Chem 1990 265 12163 12167 2373686
13. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Tora L, Gronemeyer H, Turcotte B, Gaub MP, Chambon P, Nature 1988 333 185 188 10.1038/333185a0 2835683
14. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB, Mol Endocrinol 1993 7 1256 1265 10.1210/me.7.10.1256 8123133
15. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP, Mol Endocrinol 1993 7 1244 1255 10.1210/me.7.10.1244 8264658
16. The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity. Jackson KS, Brudney A, Hastings JM, Mavrogianis PA, Kim JJ, Fazleabas AT, Reprod Sci 2007 14 137 150 10.1177/1933719106298409 17636225
17. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC, Endocrinology 2007 148 3814 3826 10.1210/en.2006-1692 17510236
18. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Osteen KG, Bruner-Tran KL, Eisenberg E, Fertil Steril 2005 83 529 537 10.1016/j.fertnstert.2004.11.026 15749474
19. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs). Wardell SE, Edwards DP, Semin Reprod Med 2005 23 9 21 10.1055/s-2005-864030 15714386
20. Progesterone receptor isoform A but not B is expressed in endometriosis. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE, J Clin Endocrinol Metab 2000 85 2897 2902 10.1210/jc.85.8.2897 10946900
21. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW, Epigenetics 2006 1 106 111 10.4161/epi.1.2.2766 17965625
22. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB, Taylor RN, Mol Hum Reprod 1999 5 651 655 10.1093/molehr/5.7.651 10381820
23. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, Bulun SE, Biol Reprod 2007 77 681 687 10.1095/biolreprod.107.061804 17625110
24. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. Trukhacheva E, Lin Z, Reierstad S, Cheng YH, Milad M, Bulun SE, J Clin Endocrinol Metab 2009 94 615 622 10.1210/jc.2008-1466 19001520
25. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Kohler G, Faustmann TA, Gerlinger C, Seitz C, Mueck AO, Int J Gynaecol Obstet 2010 108 21 25 10.1016/j.ijgo.2009.08. 020 19819448
26. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Strowitzki T, Faustmann T, Gerlinger C, Seitz C, Eur J Obstet Gynecol Reprod Biol 2010 151 193 198 10.1016/j.ejogrb.2010.04.002 20444534
27. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P, Audebert A, Manhes H, Fertil Steril 2002 77 684 692 10.1016/S0015-0282(01)03270- 8 11937116
28. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C, Hum Reprod 2010 25 633 641 10.1093/humrep/dep469 20089522
29. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial. Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N, Fertil Steril 2009 91 675 681 10.1016/j.fertnstert. 2007.12.080 18653184
30. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, Lazzeri L, Strowitzki T, Arch Gynecol Obstet 2012 285 167 173 10.1007/s00404-011-1941-7 21681516
31. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H, Mol Hum Reprod 2001 7 341 347 10.1093/molehr/7.4.341 11279296
32. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T, Taketani Y, Fertil Steril 2008 89 1344 1347 10.1016/j.fertnstert.2007.03.042 17511992
33. Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system. Shimizu Y, Mita S, Takeuchi T, Notsu T, Mizuguchi K, Kyo S, Steroids 2010 76 60 67 20851710
34. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997 67 817 821 10.1016/S0015-0282(97)81391-X 9130884
35. Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells? Karita M, Yamashita Y, Hayashi A, Yoshida Y, Hayashi M, Yamamoto H, Tanabe A, Terai Y, Ohmichi M, Fertil Steril 2011 95 889 894 10.1016/j.fertnstert.2010.12.026 21269613
36. Detection of progesterone receptor forms A and B by immunohistochemical analysis. Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL, J Clin Pathol 2001 54 624 630 10.1136/jcp.54.8.624 11477119
37. Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Goldman S, Weiss A, Almalah I, Shalev E, Mol Hum Reprod 2005 11 269 277 10.1093/molehr/gah161 15764807
38. Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition. Oh SY, Kim CJ, Park I, Romero R, Sohn YK, Moon KC, Yoon BH, Am J Obstet Gynecol 2005 193 1156 1160 10.1016/j.ajog.2005.05. 071 16157129
39. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Lessey BA, Metzger DA, Haney AF, McCarty KS Jr, Fertil Steril 1989 51 409 415 2646155
40. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Fujimoto J, Hirose R, Sakaguchi H, Tamaya T, Mol Hum Reprod 1999 5 742 747 10.1093/molehr/5.8.742 10421802
41. Endometriosis. Bulun SE, N Engl J Med 2009 360 268 279 10.1056/NEJMra0804690 19144942
42. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, Utsunomiya H, Yin P, Luo X, et al. Semin Reprod Med 2010 28 36 43 10.1055/s-0029-1242991 20104427
43. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Zeitoun KM, Bulun SE, Fertil Steril 1999 72 961 969 10.1016/S0015-0282(99)00393-3 10593363
44. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Zeitoun K, Takayama K, Michael MD, Bulun SE, Mol Endocrinol 1999 13 239 253 10.1210/me.13.2.239 9973254
45. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. Aguirre C, Jayaraman A, Pike C, Baudry M, J Neurochem 2010 115 1277 1287 10.1111/j.1471-4159.2010. 07038.x 20977477